SLC6A3 Polyclonal Antibody
Code No: BMP015
Background:
SLC6A3, also known as DAT1, is a transporter for the neurotransmitter dopamine. SLC6A3 regulates dopamine homeostasis by reuptaking dopamine released into the synaptic cleft. SLC6A3 polymorphisms are associated with nicotine addiction, especially cessation attempts from individual cigarette smoking. Polymorphisms in the SLC6A3 gene have also been reported to constitute one cause for Attention-deficit hyperactivity disorder (ADHD), the most common childhood-onset behavioral disorder.
Product Type:
Primary Antibody
Species Reactivities:
Human
Related Products:
BMP029 anti-SLC6A2/NET (polyclonal)
BMP015 anti-SLC6A3/DAT1 (polyclonal)
BMP045 anti-SLC6A4/SERT (polyclonal)
BMP046 anti-SLC6A6/TAUT (polyclonal)
BMP016 anti-SLC6A7/PROT (polyclonal)
BMP047 anti-SLC6A8/CRTR (polyclonal)
BMP038 anti-SLC6A12/BGT-1 (polyclonal)
BMP051 anti-SLC6A13/GAT2 (polyclonal)
BMP052 anti-SLC6A14/ATB0+ (polyclonal)
BMP050 anti-SLC6A15/SBAT1 (polyclonal)
BMP053 anti-SLC6A19/B0AT1 (polyclonal)
References:
1) Feng, Y., et al., Am. J. Med. Genet. 139B, 1-6 (2005)
2) Lerman, C., et al., Health Psych. 18, 14-20 (1999)
3) Sabol, S. Z., et al., Health Psych. 18, 7-13 (1999)
4) Waldman, I. D. et al., Am. J. Hum. Genet. 63, 1767-1776 (1998)
5) Cook, E. H., et al., Am. J. Hum. Genet. 56, 993-998 (1995)
6) Vandenbergh, D. J., et al., Genomics 14, 1104-1106 (1992)
Formulation:
100 uL volume of PBS containing 50% glycerol, pH 7.2. No preservative is contained.
Reactivity:
This antibody can be used to stain endogenous antigen in paraffin embedded human tissues including brain and Peyer’s patches in large intestine by immunohistochemistry. The reactivity of this antibody has been confirmed by Western blotting to detect the full-length of human SLC6A3 transiently expressed in HEK 293T cells.
Intended Use:
For Research use only. Not for use in diagnostic procedure.
|